Screener
Fulgent Genetics, Inc. FLGT Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 7:08 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-199065
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Purchase of marketable securities | (10,011) | — |
| Purchases of fixed assets | (5,202) | (4,718) |
| Acquisition of businesses, net of cash | (55,567) | — |
| Net cash provided by investing activities | 10,939 | 27,729 |
| Cash flow from financing activities: | ||
| Repurchase of common stock | (40,078) | (8,679) |
| Common stock withholding for employee tax obligations | (4,200) | (1,887) |
| Repayment of notes payable | (476) | (470) |
Item 1. Financial Statements.
FAQ
- What is Fulgent Genetics, Inc.'s investing cash flow?
- Fulgent Genetics, Inc. (FLGT) reported investing cash flow of $10.94M in Q1 2026.
- How has Fulgent Genetics, Inc.'s investing cash flow changed year-over-year?
- Fulgent Genetics, Inc.'s investing cash flow decreased by 60.6% year-over-year, from $27.73M to $10.94M.
- What is the long-term trend for Fulgent Genetics, Inc.'s investing cash flow?
- Over 2 years (2021 to 2025), Fulgent Genetics, Inc.'s investing cash flow has grown at a -54.9% compound annual growth rate (CAGR), from -$546.55M to $111.37M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about Fulgent Genetics, Inc.'s investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude